REQUEST A DEMO
Total
USD $0.00
Search more companies

H.Pio Co.,Ltd (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: H.Pio Co.,Ltd Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company principally engaged in the manufacture of health functional food. The Company manufactures and sells health functional foods such as probiotics, vitamins, collagen, lactium, omega 3, prebiotics, xantigen, and lutein. The Company s products are used to improve stomach, generate energy in the body, improve blood circulation, moisturize skin, improve sleep quality, and improve eye fatigue, among others. The Company was established on April 6, 2012. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on May 14, 2021.

Headquarters
115 Yangpyeong-Ro, Yeongdeungpo-Gu
Seoul; Seoul;

Contact Details: Purchase the H.Pio Co.,Ltd report to view the information.

Website: http://denps.com/kor

Basic Information
Total Employees:
Purchase the H.Pio Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the H.Pio Co.,Ltd report to view the information.
Registered Capital:
Purchase the H.Pio Co.,Ltd report to view the information.
Financial Auditors:
Purchase the H.Pio Co.,Ltd report to view the information.
Incorporation Date:
April 06, 2012
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
(주)에이치피오
Company Performance
Financial values in the chart are available after H.Pio Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
18.39%
Total operating revenue
18.27%
Operating profit (EBIT)
23.34%
EBITDA
28.4%
Net Profit (Loss) for the Period
31.92%
Total assets
18.16%
Total equity
2.9%
Operating Profit Margin (ROS)
0.38%
Net Profit Margin
0.84%
Return on Equity (ROE)
2.52%
Debt to Equity Ratio
1.31%
Quick Ratio
-2.53%
Cash Ratio
-0.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?